论文部分内容阅读
2012年2月24日,朗盛以私募配售形式向美企BioAmber公司投资1000万美元,BioAmber公司成立于2008年10月,现有40名全职员工,总部位于美国明尼苏达州明尼阿波利斯市。BioAmber是新一代化学公司,拥有专业技术平台,能结合工业生物科技、创新净化流程和化学催化工艺,将可再生的生物原料转化为化学品来制造日常生产生活中所需要的产品,包括塑料、食品添加剂和个人保健品等。BioAmber生产生物基琥珀酸的装置是全球最大的生物及
On February 24, 2012, LANXESS invested US $ 10 million in a private placement with BioAmber, a US company founded in October 2008 with 40 full-time employees and headquartered in Minneapolis, Minnesota . BioAmber is a next-generation chemical company with a dedicated technology platform that combines industrial biotechnology, innovative purification processes and chemical catalysis processes to convert renewable biological feedstock into chemicals to produce the products that are needed in everyday life, including plastics, Food additives and personal care products. BioAmber bio-based succinic acid device is the world’s largest biological and